Update on the epidemiology and management of cryptococcal meningitis

Bibliography

• Park BJ, Wannemuehler KA, Marston BJ, Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23:525-30
   PubMed Web of Science ®Google Scholar
• Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 2008;9:551-60
   PubMed Web of Science ®Google Scholar
• Liu OW, Chun CD, Chow ED, Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 2008;135:174-88
   PubMed Web of Science ®Google Scholar
• De Jesus MD, Nicola AM, Chow SK, Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence 2010;1:500-8
   PubMed Web of Science ®Google Scholar
• Chow SK, Casadevall A. Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. Vaccine 2011;29:1891-8
   PubMed Web of Science ®Google Scholar
• Xue C, Liu T, Chen L, Role of an expanded inositol transporter repertoire in Cryptococcus neoformans sexual reproduction and virulence. mBio 2010;1:e00084-10
   PubMed Web of Science ®Google Scholar
• Eisenman HC, Chow SK, Tse KK, The effect of L-DOPA on Cryptococcus neoformans growth and gene expression. Virulence 2011;2:329-36
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog 2007;3:e101
   PubMed Web of Science ®Google Scholar
• Means TK, Mylonakis E, Tampakakis E, Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med 2009;206:637-53
   PubMed Web of Science ®Google Scholar
• Byrnes EJ III, Li W, Lewit Y, Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010;6:e1000850
   PubMed Web of Science ®Google Scholar
• Hoang LM, Maguire JA, Doyle P, Cryptococcus neoformans infections at Vancouver hospital and health sciences centre (1997 – 2002): epidemiology, microbiology and histopathology. J Med Microbiol 2004;53:935-40
   PubMed Web of Science ®Google Scholar
• Byrnes EJ III, Marr KA. The outbreak of Cryptococcus gattii in western North America: epidemiology and clinical issues. Curr Infect Dis Rep 2011;13:256-61
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Emergence of Cryptococcus gattii – Pacific Northwest, 2004 – 2010. MMWR Morb Mortal Wkly Rep 2010;59:865-8
   PubMedGoogle Scholar
• Fraser JA, Giles SS, Wenink EC, Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 2005;437:1360-4
   PubMed Web of Science ®Google Scholar
• Ma H, Hagen F, Stekel DJ, The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc Natl Acad Sci USA 2009;106:12980-5
   PubMed Web of Science ®Google Scholar
• Lindsley MD, Mekha N, Baggett HC, Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 2011;53:321-5
   PubMed Web of Science ®Google Scholar
• Shelburne SA III, Darcourt J, White AC Jr, The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:1049-52
   PubMed Web of Science ®Google Scholar
• Sungkanuparph S, Filler SG, Chetchotisakd P, Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin Infect Dis 2009;49:931-4
   PubMed Web of Science ®Google Scholar
• Bicanic T, Brouwer AE, Meintjes G, Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009;23:701-6
   PubMed Web of Science ®Google Scholar
• Wijewardana I, Jarvis JN, Meintjes G, Large volume lumbar punctures in cryptococcal meningitis clear cryptococcal antigen as well as lowering pressure. J Infect 2011;63:484-6
   PubMed Web of Science ®Google Scholar
• Perfect JR, Dismukes WE, Dromer F, Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010;50:291-322
   PubMed Web of Science ®Google Scholar
• Sun HY, Alexander BD, Lortholary O, Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis 2009;49:1721-8
   PubMed Web of Science ®Google Scholar
• Byrnes EJ III, Bartlett KH, Perfect JR, Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect 2011;13:895-907
   PubMed Web of Science ®Google Scholar
• Lee YC, Wang JT, Sun HY, Chen YC. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect 2011;44:338-45
   PubMedGoogle Scholar
• Loyse A, Wilson D, Meintjes G, Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis 2011; 54(1):121-8
   PubMed Web of Science ®Google Scholar
• Nussbaum JC, Jackson A, Namarika D, Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Clin Infect Dis 2010;50:338-44
   PubMed Web of Science ®Google Scholar